Quinn Opportunity Partners LLC Amarin Corp Plcuk Transaction History
Quinn Opportunity Partners LLC
- $1.33 Billion
- Q4 2024
A detailed history of Quinn Opportunity Partners LLC transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Quinn Opportunity Partners LLC holds 1,106,539 shares of AMRN stock, worth $674,988. This represents 0.04% of its overall portfolio holdings.
Number of Shares
1,106,539
Previous 597,550
85.18%
Holding current value
$674,988
Previous $376,000
41.22%
% of portfolio
0.04%
Previous 0.04%
Shares
11 transactions
Others Institutions Holding AMRN
# of Institutions
177Shares Held
69.9MCall Options Held
258KPut Options Held
98K-
Sarissa Capital Management LP Greenwich, CT24.9MShares$15.2 Million3.89% of portfolio
-
Kynam Capital Management, LP Princeton, NJ12.4MShares$7.57 Million0.64% of portfolio
-
Eversept Partners, LP New York, NY3.31MShares$2.02 Million0.16% of portfolio
-
Morgan Stanley New York, NY2.55MShares$1.55 Million0.0% of portfolio
-
Scp Investment, LP2.5MShares$1.53 Million1.0% of portfolio
About AMARIN CORP PLCUK
- Ticker AMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 403,206,016
- Market Cap $246M
- Description
- Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...